Yisheng Pan

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Combination Therapy

Top Venues

Journal of experimental & clinical cancer research : CR

Cancer biology & medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Mei Feng, Fangyanni Wang, Xinyu Liu, Tingting Hao, Ning Zhang, Mi Deng, Yisheng Pan, Ruirui Kong
Neutrophils as key regulators of tumor immunity that restrict immune checkpoint blockade in liver cancer. Cancer biology & medicine (2023)
Mei Feng, Hao Xu, Wenyuan Zhou, Yisheng Pan
The BRD4 inhibitor JQ1 augments the antitumor efficacy of abemaciclib in preclinical models of gastric carcinoma. Journal of experimental & clinical cancer research : CR 42 (1) (2023)
Mei Feng, Hao Xu, Wenyuan Zhou, Yisheng Pan
The BRD4 inhibitor JQ1 augments the antitumor efficacy of abemaciclib in preclinical models of gastric carcinoma. Journal of experimental & clinical cancer research : CR 42 (1) (2023)
Mei Feng, Hao Xu, Wenyuan Zhou, Yisheng Pan
The BRD4 inhibitor JQ1 augments the antitumor efficacy of abemaciclib in preclinical models of gastric carcinoma. Journal of experimental & clinical cancer research : CR 42 (1) (2023)
Hao Xu, Yisheng Pan, Ning Zhang
A breakthrough in liver regeneration for treatment of liver cancer. Cancer biology & medicine 18 (3) (2022)